Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma

Immune-related myositis is one of the rare immune-related adverse events whose underlying precise mechanisms are not fully understood. Here, we describe a case of immune-related myositis that developed after four cycles of combination therapy with nivolumab plus ipilimumab for the treatment of metas...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Okubo, Naoya, Kijima, Toshiki, Nukui, Akinori, Kamai, Takao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2020
Gaiak:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482462/
https://ncbi.nlm.nih.gov/pubmed/32912886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-235199
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak